Lead: Scope Expansion Initiative to support Medical / Medical Affairs• As part of the key imperative to expand organizational scope, leading the initiative to expand scope of organization to serve Late Development / Medical Interventional and Non-Interventional trials. Developed strategic 12-month implementation and prioritization roadmap.• Responsible to forging relationships with new stakeholders, building close relationships, and synergizing efforts across BIA R&D for Medical and GDO Late Dev leadership and partners. • Oversee the adaption of existing tools and creation of new processes in an ambiguous environment, leading cross-functional alignment workstream with Medical, GDO and external CRO partners. Organize and synthesize information and processes to create a unique Medical-specific operating model and deliverables. • Convert, train, mentor and hire staff to build out new team of BMS employees, contract employees and external consultants.Lead: Clinical Forecasting and Enrollment Tracking Team • Lead monthly closing activities, including consolidated reporting and deliverables across BMS Full Dev, Early Dev and Late Dev priority studies. Aggregate information and reporting, review with GDO senior leadership and prep summary for BMS senior leadership and enterprise-wide consumption,• Created and implemented updated R&D Full Development Priority study tracking, including new deliverables aggregation and review, monthly presentation to GDO leadership, and deliverables presented to BMS leadership for highest priority studies.• Work closely with R&D Finance to ensure consistency and flow of timelines and financial impact to LTFP. • Instituted study-level prospective trending analysis and models for all GDD enrolling studies, proving insights and projections for study teams and GDD leadership.

Directed the development, oversight and implementation of financial and operational initiatives and collaborations across Women’s Health organization, leading a leadership team of 15 reports (and 400+ indirect reports), directly responsible and accountable for a $125m organization encompassing all R&D Ops, Clinical and Clinical Trial Ops.

Divisions of Gynecologic Oncology and General OB/GYNManage the operations and financials of two divisions within the Department of OB/GYN including development and responsibility for a combined operating budget of approximately $18 million and clinical revenue of approximately $15 million. Responsible for the oversight of physicians’ schedules, practice and operations totaling over 45,000 visits across five practice locations. Consistently develop tools and reports to assist in analytic decision making. Developed business plans to analyze the viability of expansion projects.

Collaborated with senior leadership from 32 departments to develop and manage the medical college’s $1.5 billion annual operating budget. • Synergized information across entire institution to align goals of internal organizations and Enterprise Executive Leadership, including in-depth modeling and SOTP financial planning.• Led management reporting efforts centered around monthly close and quarterly consolidation and reporting to senior management and Board of Trustees.

• Developed complex, scenario-based financial analysis and models based on risk analysis private company valuation, financial and discounted cash flow modeling, long-term initiatives/commitments and overall investment exposure. • Managed the timeline and deliverables for prospective clients and provided clear and concise communication to internal stakeholders at weekly governance meeting.